Medicenna Therapeutics Corp. (MDNAF)
OTCMKTS · Delayed Price · Currency is USD
0.7000
-0.0290 (-3.98%)
May 30, 2025, 4:00 PM EDT

Medicenna Therapeutics Market Cap

Medicenna Therapeutics has a market cap or net worth of $57.58 million as of May 30, 2025. Its market cap has decreased by -57.24% in one year.

Market Cap
57.58M
Enterprise Value
35.90M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.70

Market Cap Chart

Since March 8, 2017, Medicenna Therapeutics's market cap has increased from 48.70M to 57.58M, an increase of 18.24%. That is a compound annual growth rate of 2.06%.

History

DateMarket Cap% Change
May 30, 202557.58M-35.80%
Dec 31, 202489.69M305.00%
Dec 29, 202322.15M-32.75%
Dec 30, 202232.93M-63.24%
Dec 31, 202189.58M-62.05%
Dec 31, 2020236.06M163.81%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Endo Inc. 1.62B
Veradigm 713.27M
Nika Pharmaceuticals 667.04M
Tian'an Technology Group 614.49M
Elite Pharmaceuticals 575.83M
Glass House Brands 459.97M
CytoDyn 434.59M
Northwest Biotherapeutics 388.39M
Market Cap Rankings